T1	Participants 67 98	refractory rheumatoid arthritis
T2	Participants 101 186	Fifty-two patients with severe rheumatoid arthritis (RA) from four Australian centres
T3	Participants 788 926	There was a mean increase in serum creatinine concentration associated with CSA; no persons were withdrawn from the study for this reason.
T4	Participants 927 1137	Seven CSA recipients (three gastrointestinal symptoms, two neurological symptoms, two other) and 12 AZA recipients (six gastrointestinal symptoms, four inefficacy, two other) withdrew from treatment prematurely
T5	Participants 1336 1370	severely affected patients with RA
